Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CfaE is the minor, tip-localized adhesive subunit of the Colonization Factor Antigen I (CFA/I) fimbriae, which are archetypal Class 5 fimbriae found in Enterotoxigenic Escherichia coli (ETEC). It is a critical virulence factor that mediates the initial attachment of the bacteria to the human intestinal epithelium, a prerequisite for colonization and subsequent toxin delivery. Structurally, CfaE is composed of two domains: an N-terminal adhesin domain that contains the receptor-binding site and a C-terminal pilin domain that anchors the protein to the fimbrial shaft. The receptor-binding pocket of CfaE, particularly involving the conserved Arg181 residue, is the primary site targeted by neutralizing antibodies. As ETEC is a leading cause of traveler's diarrhea and childhood mortality in developing countries, CfaE has become a high-priority target for vaccine development. Current therapeutic strategies include the use of CfaE-based subunit vaccines, fusion proteins like CfaE-dmLT, and monoclonal antibodies designed to block bacterial adhesion. By preventing the binding of ETEC to host cells, these interventions aim to provide broad protection against infections caused by CFA/I-expressing strains.
Inhibition of bacterial adhesion to host intestinal epithelial cells by neutralizing the tip adhesin; induction of protective mucosal and systemic antibodies (IgA/IgG) against the receptor-binding domain.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization factor antigen I fimbrial subunit E (CfaE) (CfaE).